Jenscare Scientific Co., Ltd. (HKG:9877)
Hong Kong
· Delayed Price · Currency is HKD
8.00
-0.01 (-0.12%)
Mar 10, 2026, 1:11 PM HKT
Jenscare Scientific Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 94.17 | 68.18 | 150.31 | 219.7 | 238.51 | 131.48 |
| Research & Development | 149.29 | 142.64 | 288.15 | 291.58 | 265.34 | 170.63 |
| Operating Expenses | 243.46 | 210.82 | 438.46 | 511.28 | 503.84 | 302.11 |
| Operating Income | -231.63 | -210.82 | -438.46 | -511.28 | -503.84 | -302.11 |
| Interest Expense | -0.29 | -0.29 | -0.14 | -0.11 | -0.13 | -0.59 |
| Interest & Investment Income | 10.78 | 11.25 | 19.33 | 8.36 | 1.77 | 0.13 |
| Earnings From Equity Investments | - | - | 18.95 | 16.17 | 1.34 | - |
| Currency Exchange Gain (Loss) | -6.54 | 2.91 | 3.17 | 34.62 | -6.84 | - |
| Other Non Operating Income (Expenses) | -22.99 | 7.06 | 18.24 | 10.62 | 0.54 | 1.4 |
| EBT Excluding Unusual Items | -250.67 | -189.89 | -378.92 | -441.62 | -507.16 | -301.18 |
| Gain (Loss) on Sale of Investments | 7.07 | 10.84 | -0.17 | 0.72 | 6.49 | 1.5 |
| Gain (Loss) on Sale of Assets | -0.06 | -0.09 | -0.01 | -0.01 | - | - |
| Asset Writedown | -6.69 | -6.69 | - | - | - | - |
| Pretax Income | -250.35 | -185.83 | -379.1 | -440.91 | -500.67 | -299.67 |
| Earnings From Continuing Operations | -250.35 | -185.83 | -379.1 | -440.91 | -500.67 | -299.67 |
| Minority Interest in Earnings | 5.54 | 8.32 | 7.36 | 1.6 | 0.16 | 0.23 |
| Net Income | -244.81 | -177.51 | -371.74 | -439.31 | -500.52 | -299.45 |
| Net Income to Common | -244.81 | -177.51 | -371.74 | -439.31 | -500.52 | -299.45 |
| Shares Outstanding (Basic) | 407 | 409 | 417 | 365 | 338 | 279 |
| Shares Outstanding (Diluted) | 407 | 409 | 417 | 365 | 338 | 279 |
| Shares Change (YoY) | -1.97% | -1.97% | 14.17% | 7.96% | 21.43% | - |
| EPS (Basic) | -0.60 | -0.43 | -0.89 | -1.20 | -1.48 | -1.07 |
| EPS (Diluted) | -0.60 | -0.43 | -0.89 | -1.20 | -1.48 | -1.07 |
| Free Cash Flow | -258.68 | -288.81 | -300.64 | -180.14 | -155.17 | -48.95 |
| Free Cash Flow Per Share | -0.64 | -0.71 | -0.72 | -0.49 | -0.46 | -0.18 |
| EBITDA | -223.28 | -201.62 | -429.68 | -504.82 | -500.44 | -299.66 |
| D&A For EBITDA | 8.35 | 9.2 | 8.78 | 6.46 | 3.41 | 2.44 |
| EBIT | -231.63 | -210.82 | -438.46 | -511.28 | -503.84 | -302.11 |
Source: S&P Capital IQ. Standard template.
Financial Sources.